Predicting optimal treatment regimens for patients with HR+/HER2-  breast cancer using machine learning based on electronic health records

Conclusion: RSF may help inform optimal treatment choices and improve outcomes for patients with HR+/HER2- MBC.PMID:33980048 | DOI:10.2217/cer-2020-0230

Source: Journal of Comparative Effectiveness Research - May 13, 2021 Category: General Medicine Authors: Zhanglin Lin Cui Zbigniew Kadziola Ilya Lipkovich Douglas E Faries Kristin M Sheffield Gebra Cuyun Carter Source Type: research